Pelthos Therapeutics Inc. (PTHS) earnings · rev $16.8M
These earnings events as JSON? API free 100/dayPelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
This PTHS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
When the next PTHS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for PTHS. We will not invent a beat or miss.
Not investment advice. Full PTHS research stays on the stock page; the tape stays on the quote page.
PTHS earnings FAQ
What are PTHS's latest revenue and net income?
Latest cached Pelthos Therapeutics Inc. (PTHS) revenue for Dec 31, 2025 was $16.8M. Net income was -$43.3M. Statements: https://lician.com/financials/pths
What is PTHS's latest diluted EPS?
Latest cached Pelthos Therapeutics Inc. (PTHS) diluted EPS for Dec 31, 2025 was -$23.04.
What period does the latest PTHS earnings print cover?
The latest cached Pelthos Therapeutics Inc. (PTHS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are PTHS earnings listed?
Cached earnings facts for Pelthos Therapeutics Inc. (PTHS) are listed at https://lician.com/earnings/pths. Statements: https://lician.com/financials/pths
Not investment advice.